WordNet

being long-lasting and recurrent or characterized by long suffering; "chronic indigestion"; "a chronic shortage of funds"; "a chronic invalid"
of long duration; "chronic money problems" (同)continuing
habitual; "a chronic smoker" (同)inveterate
severe respiratory disease of birds that takes the form of an acute rapidly fatal pneumonia in young chickens and turkeys (同)brooder pneumonia
an opportunistic infection by a fungus of the genus Aspergillus; characterized by inflammation and lesions of the ear and other organs
disease especially in agricultural workers caused by inhalation of Aspergillus spores causing lumps in skin and ears and respiratory organs

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 慢性肺アスペルギルス症の治療 treatment of chronic pulmonary aspergillosis
2. 慢性肺アスペルギルス症の臨床症状および診断 clinical manifestations and diagnosis of chronic pulmonary aspergillosis
3. アレルギー性気管支肺アスペルギルス症の臨床症状および診断 clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis
4. 侵襲性アスペルギルス症の疫学および臨床症状 epidemiology and clinical manifestations of invasive aspergillosis
5. 大量喀血：原因 massive hemoptysis causes

Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.

Moon SM1, Park HY1, Jeong BH1, Jeon K1, Lee SY2, Koh WJ3.
Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2015 Jan;59(1):663-5. doi: 10.1128/AAC.04075-14. Epub 2014 Oct 13.
We investigated the effects of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis. Serum itraconazole concentrations were significantly lower in patients who received itraconazole with rifampin (median, 0.1 μg/ml; P < 0.001) or rifabutin (median,
PMID 25313207

Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry.

Camara B1, Reymond E, Saint-Raymond C, Roth H, Brenier-Pinchart MP, Pinel C, Cadranel J, Ferretti G, Pelloux H, Pison C; Grenoble Aspergillus Committee.
The clinical respiratory journal.Clin Respir J.2015 Jan;9(1):65-73. doi: 10.1111/crj.12105. Epub 2014 Feb 17.
INTRODUCTION: Our objective was to investigate characteristics risk factors and outcomes of patients with chronic pulmonary aspergillosis (CPA).METHODS: The Aspergillosis Committee prospectively collected Aspergillus notifications from January 2000 to December 2011. A retrospective analysis of data
PMID 24406138

Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis.

Oliva A1, Flori P2, Hennequin C3, Dubus JC4, Reynaud-Gaubert M5, Charpin D6, Vergnon JM7, Gay P8, Colly A9, Piarroux R10, Pelloux H11, Ranque S12.
Journal of clinical microbiology.J Clin Microbiol.2015 Jan;53(1):248-54. doi: 10.1128/JCM.02690-14. Epub 2014 Nov 12.
Immunoprecipitin detection (IPD) is the current reference confirmatory technique for anti-Aspergillus antibody detection; however, the lack of standardization is a critical drawback of this assay. In this study, we evaluated the performance of the Aspergillus Western blot (Asp-WB) IgG kit (LDBio Dia
PMID 25392351